More than 100 researchers from academia, government, and industry come together to share existing knowledge, new approaches, best practices, and continued challenges in pediatric drug formulation.

Research team led by Dr. Linda Wastila aims to understand how a nationwide effort to reduce the use of antipsychotic medications in long-term care facilities has impacted those facilities’ use of other medications and patient health outcomes.

New company established by School of Pharmacy faculty members releases its first software platform designed to assist strategic decision making across the fields of drug development and individualized patient care.

Interactive event aims to improve the way research is understood and talked about by community residents, patients, researchers, and trainees.

Presentations aimed to help shape how patients, caregivers, community members, and other stakeholders conduct patient-centered research in community-based settings and health care systems.

Event sponsored by the University of Maryland Center of Excellence in Regulatory Science and Innovation addressed current knowledge gaps in the dissolution similarity evaluation of pharmaceutical products.

Dr. Lisa Jones honored for her research and recent achievements focused on cutting-edge investigations of biomolecular processes in living organisms.

Third-year student pharmacists take the gold for their proposal to establish regulatory standards that protect patient privacy for individuals using wearable and implantable medical technologies.

Testimony emphasized the need for alternative pain management treatments, and examined how pharmacists can help ensure that patients who use opioids do so safely and effectively.

Special ceremony honors five graduate students in the PhD in Pharmaceutical Health Services Research program with awards recognizing their outstanding scholastic achievements.

Succeeding Dr. Frank Palumbo as graduate program director, Dr. Danya Qato plans to streamline curricular requirements, while highlighting accomplishments and enhancing career preparedness of students.

The new 16-month program provides students with the knowledge and skills necessary to obtain high-level research positions in biopharmaceutical companies and the federal government.